Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.400
-0.030 (-0.87%)
Apr 29, 2026, 2:27 PM EDT - Market open
Rocket Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 371 | 380 | 1,312 | 2,702 | 1,481 | 1,407 | |
| Market Cap Growth | -33.97% | -71.04% | -51.45% | 82.43% | 5.29% | -57.65% | |
| Enterprise Value | 207 | 182 | 1,102 | 2,290 | 1,197 | 1,008 | |
| Last Close Price | 3.43 | 3.51 | 12.57 | 29.97 | 19.57 | 21.83 | |
| PB Ratio | 1.34 | 1.37 | 2.83 | 5.49 | 3.03 | 3.09 | |
| P/TBV Ratio | 1.74 | 1.78 | 3.29 | 6.31 | 3.49 | 3.32 | |
| Debt / Equity Ratio | 0.09 | 0.09 | 0.06 | 0.05 | 0.05 | 0.05 | |
| Net Debt / Equity Ratio | -0.59 | -0.59 | -0.75 | -0.71 | -0.68 | -0.80 | |
| Net Debt / EBITDA Ratio | 0.75 | 0.75 | 1.32 | 1.40 | 1.53 | 2.28 | |
| Net Debt / FCF Ratio | 0.86 | 0.86 | 1.61 | 1.65 | 1.79 | 2.84 | |
| Quick Ratio | 6.26 | 6.26 | 9.15 | 7.69 | 9.10 | 17.54 | |
| Current Ratio | 6.38 | 6.38 | 9.30 | 7.80 | 9.30 | 17.69 | |
| Return on Equity (ROE) | -60.27% | -60.27% | -54.14% | -50.01% | -46.98% | -35.29% | |
| Return on Assets (ROA) | -33.29% | -33.29% | -31.21% | -28.69% | -26.68% | -19.10% | |
| Return on Capital Employed (ROCE) | -76.10% | -76.10% | -56.10% | -49.60% | -43.70% | -35.00% | |
| Earnings Yield | -60.14% | -58.74% | -19.73% | -9.09% | -14.98% | -12.02% | |
| FCF Yield | -51.33% | -50.14% | -16.43% | -7.82% | -12.59% | -9.15% | |
| Buyback Yield / Dilution | -17.21% | -17.21% | -12.85% | -23.27% | -7.77% | -14.18% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.